Skip to content

Viatris Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 5, 2026 results vs estimates

Viatris Inc · E.VTRS.NASDAQ · United States
Use symbol E.VTRS.NASDAQ in our API & Excel add-in to retrieve this data ↓
19.20
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 27.77%

Viatris Inc Forecast

Viatris Inc short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 27.8% a year, a typical one-standard-deviation range is 18.45–19.95 over a week, 17.66–20.74 over a month and 13.87–24.53 over a year. (Signals as of 1 Nov 2026.)

Viatris Inc Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Viatris Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Viatris Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Viatris Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Viatris Inc
P/S
1.50x
Stretched vs own history
QoQ +16.2%
YoY +73.6%
now 1.49750.88 low1.62 high
ⓘP/S As of 22 Nov 2026.See Viatris Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Viatris Inc
P/B
1.61x
Stretched vs own history
QoQ +21.0%
YoY +101.3%
now 1.61140.82 low1.75 high
ⓘP/B As of 22 Nov 2026.See Viatris Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Viatris Inc
EV/EBITDA
11.82x
Stretched vs own history
QoQ +3.3%
YoY —
now 11.821411.41 low12.8 high
ⓘEV/EBITDA As of 22 Nov 2026.See Viatris Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Viatris Inc
EV/Sales
2.29x
Stretched vs own history
QoQ +8.6%
YoY +25.7%
now 2.29081.84 low2.42 high
ⓘEV/Sales As of 22 Nov 2026.See Viatris Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Viatris Inc
FCF Yield
9.3%
Weak vs own history
QoQ −6.2%
YoY −29.5%
now 9.25768.28 low12.85 high
ⓘFCF Yield As of 22 Nov 2026.See Viatris Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Viatris Inc
Earnings Yield
-2.8%
Mid-range vs own history
QoQ +27.4%
YoY −90.9%
now -2.7561-29.65 low-1.44 high
ⓘEarnings Yield As of 22 Nov 2026.See Viatris Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Viatris Inc
Dividend Yield
2.5%
Weak vs own history
QoQ −14.3%
YoY −45.9%
now 2.51712.32 low4.55 high
ⓘDividend Yield As of 22 Nov 2026.See Viatris Inc returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Viatris Inc
Market Cap
$22.1B
Highest in 5 years
QoQ +16.2%
YoY +81.0%
now 22053.1212,450 low23,914 high
ⓘMarket Cap As of 22 Nov 2026.See Viatris Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Viatris Inc
Net Debt
$11.7B
Low vs own history
QoQ −3.6%
YoY −13.8%
now 11682.911,683 low13,558 high
ⓘNet Debt As of 22 Nov 2026.See Viatris Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Viatris Inc
Net Debt / EBITDA
4.09x
Mid-range vs own history
QoQ −8.2%
YoY —
now 4.09384.09 low4.76 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Viatris Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Viatris Inc
Current Ratio
1.55x
Mid-range vs own history
QoQ −2.1%
YoY +14.8%
now 1.55171.3 low1.6 high
ⓘCurrent Ratio As of 22 Nov 2026.See Viatris Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Viatris Inc
Quick Ratio
0.97x
Mid-range vs own history
QoQ +1.0%
YoY +22.9%
now 0.97470.74 low1.03 high
ⓘQuick Ratio As of 22 Nov 2026.See Viatris Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Viatris Inc
Interest Coverage
0.09x
Mid-range vs own history
QoQ −148.2%
YoY −101.2%
now 0.0876-7.16 low0.09 high
ⓘInterest Coverage As of 22 Nov 2026.See Viatris Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Viatris Inc
Debt / Equity
0.99x
Mid-range vs own history
QoQ +3.9%
YoY +2.6%
now 0.99240.96 low1 high
ⓘDebt / Equity As of 22 Nov 2026.See Viatris Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Viatris Inc
Piotroski F-Score
6
Mid-range vs own history
QoQ 0.0%
YoY +50.0%
now 64 low6 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Viatris Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Viatris Inc
Altman Z-Score
1.16
Strong vs own history
QoQ +7.9%
YoY +141.1%
now 1.15890.49 low1.21 high
ⓘAltman Z-Score As of 22 Nov 2026.See Viatris Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  18 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Viatris Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Viatris Inc fundamentals: income statement, balance sheet & cash flow

Viatris Inc reported revenue of $14.30bn and net income of -$3.51bn in FY2025, the year ended 31 December 2025 — revenue down 3.0% and net income down 454.2% on the prior year. Free cash flow was $1.94bn. These figures are as reported in the filings, not restated: 41 fiscal years and 164 quarters of history, back to December 1985. 138 FINRA short-interest settlements are published alongside them, back to November 2020.

Revenue (FY2025)
$14.30bn
-3.0%
Net income
-$3.51bn
-454.2%
Gross margin
35.06%
Free cash flow
$1.94bn
-2.0%
Net debt
$13.35bn
Shares short (30 Oct 2026)
35.24m
4.04 days to cover
Viatris Inc income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue14.3014.7415.4316.2617.89
Cost of revenue9.299.128.999.7712.31
Gross profit5.015.626.446.505.58
Research & development0.970.810.810.660.68
Selling, general & admin.———4.18—
Operating income-2.660.010.771.61-0.03
EBITDA-0.402.643.526.434.48
Interest expense0.470.550.570.590.64
Pre-tax income-3.67-0.620.202.81-0.66
Income tax-0.150.010.150.730.60
Net income-3.51-0.630.052.08-1.27

Download Viatris Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.VTRS.NASDAQ&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 41 fiscal years and 164 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Viatris Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Viatris Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Viatris Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Viatris Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Viatris Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Viatris Inc (United States)

Viatris Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Viatris Inc?
Viatris Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Viatris Inc price?
The latest close is 19.2 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Viatris Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Viatris Inc?
20-day realised volatility is 27.8% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 8.0% over a month and 3.9% over a week.
What factors affect Viatris Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Viatris Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Viatris Inc?
58 backtested tactical asset allocation strategies trade Viatris Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Viatris Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Viatris Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Viatris Inc historical data?
In the Free historical data section of this page: the last 10 years of Viatris Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Viatris Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Viatris Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.VTRS.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2019.63
2026-11-1919.88
2026-11-1820.28
2026-11-1720.45
2026-11-1620.74
2026-11-1320.82
2026-11-1220.67
2026-11-1121.06
2026-11-1020.85
2026-11-0920.49
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.